reference/20129632

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20129632

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	10
issn	1178-6930
pageRange	205-10
publicationName	OncoTargets and Therapy
startingPage	205
bibliographicCitation	Carpiuc KT, Rosti G, Castagnetti F, Treur M, Stephens J. Indirect comparisons of second-generation tyrosine kinase inhibitors in CML: case study using baseline population characteristics. Onco Targets Ther. 2010 Oct 11;3():205–10. PMID: 21124747; PMCID: PMC2994202.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_68302cfe34960dd7076ea60de9cb8c08 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1aed588c4b14ea39faa2567da3071bef http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db6666491972ff8d61642ddf33611347 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_690a0634fdf80b94ec860ac9db2879d2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b03bd17ddbea00dbe015efac46f1e109
date	2010-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC2994202 https://doi.org/10.2147/ott.s13052 https://pubmed.ncbi.nlm.nih.gov/21124747
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37198 https://portal.issn.org/resource/ISSN/1178-6930
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Indirect comparisons of second-generation tyrosine kinase inhibitors in CML: case study using baseline population characteristics
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9727

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128433595 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247851103 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127400640 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129879136 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459

Total number of triples: 30.